EKSO
Ekso Bionics·NASDAQ
--
--(--)
--
--(--)
6.44 / 10
Outperform
Analyst coverage is limited to one neutral rating with a 66.7% historical win rate but negative average return. Fund‑flow score is 7.33 (good) yet overall inflow trend is negative, only small investors show positivity. Sentiment leans outperformance, but outlook remains mixed.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-31
InstitutionHC Wainwright & Co.
Times predicted3
Historical Win Rate66.7%
Is money flowing into or out of EKSO?
- EKSO holds a Bullish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.44/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
